Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZBTB38 Inhibitors

ZBTB38 inhibitors are a class of chemical compounds designed to specifically target ZBTB38, a transcription factor belonging to the ZBTB (zinc finger and BTB) family of proteins, which play a crucial role in regulating gene expression. ZBTB38 contains two essential domains that define its function: the zinc finger domain, which binds to specific DNA sequences, and the BTB (Broad-Complex, Tramtrack, and Bric-à-Brac) domain, which mediates protein-protein interactions. ZBTB38 is involved in both gene activation and repression, depending on the context, by binding to regulatory regions of DNA and recruiting other proteins such as coactivators or corepressors. The BTB domain facilitates the interaction with other regulatory proteins, often chromatin remodelers or histone modifiers, which help control chromatin structure and gene accessibility. Inhibitors of ZBTB38 disrupt its ability to bind DNA or interfere with its recruitment of essential cofactors, resulting in altered gene expression patterns.

The mechanisms of action of ZBTB38 inhibitors can vary depending on the chemical structure of the compound. One common strategy involves targeting the zinc finger motifs, which are responsible for the protein's DNA-binding activity. Inhibitors may chelate the zinc ions that are necessary to stabilize these motifs, thereby preventing ZBTB38 from interacting with its target DNA sequences. Without proper DNA binding, ZBTB38 cannot regulate the transcription of its target genes. Alternatively, inhibitors can act by disrupting the BTB domain, which is critical for protein-protein interactions required for forming transcriptional regulatory complexes. By inhibiting these interactions, ZBTB38 inhibitors block the protein's ability to recruit coactivators or corepressors, further impairing its role in gene regulation. The study of ZBTB38 inhibitors provides important insights into the broader mechanisms of transcriptional control, highlighting the importance of zinc finger and BTB domain-containing proteins in maintaining the balance of gene expression and cellular function.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine could decrease methylation on the ZBTB38 promoter, which may lead to a downregulation of ZBTB38 expression through changes in chromatin accessibility.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine's inhibition of DNA methylation could lead to a reduction in ZBTB38 expression by altering the transcriptional control of the gene, potentially diminishing its mRNA synthesis.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid may downregulate ZBTB38 by inhibiting histone deacetylases, resulting in hyperacetylated chromatin that could suppress ZBTB38 gene transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A could inhibit the transcriptional initiation of ZBTB38 by promoting an open chromatin state, which often leads to transcriptional silencing of certain genes.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG 108 could reduce the expression of ZBTB38 by blocking DNA methyltransferase activity, potentially leading to promoter demethylation and subsequent transcriptional silencing.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium Butyrate may lower ZBTB38 expression levels by inhibiting histone deacetylase, which can lead to an increased acetylation state that often correlates with gene silencing.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A could decrease ZBTB38 gene transcription by binding to DNA in the promoter region, thereby preventing the assembly of transcriptional machinery.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$52.00
$87.00
7
(1)

Disulfiram could lead to a decrease in ZBTB38 expression by inhibiting DNA methyltransferase, potentially leading to altered transcription factor binding.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein may downregulate ZBTB38 by inhibiting DNA methyltransferase, which could cause hypomethylation and repression of the ZBTB38 gene's transcription.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$79.00
$300.00
32
(2)

Parthenolide may suppress the expression of ZBTB38 by inhibiting the NF-kB pathway, which might be involved in the transcriptional initiation of the ZBTB38 gene.